on 6 April 2022, Shenzhen Zhong Ji Health Science Company Limited signed a commodity supply contract with Sinopharm Holdings Hubei Guoda Pharmacy Co,. Ltd. The signing of the Supply Contract marks the formal formation of a strategic partnership between the two parties, which is the first step of the Group's retail coverage in Mainland China after obtaining the legal rights to distribute ZJ1 VC Extended-Release Tablets, a biological product from the United States, on the Mainland. The Group's next endeavour is continuously enhancing the development and collaboration with the top 100 offline pharmaceutical retailers in China, with a view to developing a more convenient physical channel for the public.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.196 HKD | -9.68% | -19.67% | +45.19% |
1st Jan change | Capi. | |
---|---|---|
+45.19% | 12.67M | |
-8.19% | 49.94B | |
-5.99% | 30.73B | |
+52.41% | 27.02B | |
+27.75% | 25.12B | |
+14.89% | 17.46B | |
+1.96% | 12.69B | |
+15.57% | 10.53B | |
+13.77% | 8.16B | |
-27.14% | 7.53B |
- Stock Market
- Equities
- 767 Stock
- News Zhong Ji Longevity Science Group Limited
- Shenzhen Zhong Ji Health Science Company Limited Signs A Commodity Supply Contract with Sinopharm Holdings Hubei Guoda Pharmacy Co,. Ltd